Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abnormal, adenosine, adolescence, ADPKD, adulthood, aerosolized, airway, AMT, apical, Article, biallelic, biobank, biopsy, blind, blood, blot, born, Brazil, briefly, budget, burdensome, Cantor, CFF, cGCP, cGLP, chloride, CHM, Choroideremia, ciliary, Citigroup, clarity, collateral, compliant, Congenital, correlation, cyclic, cytosolic, databank, deducing, degeneration, degenerative, Deloitte, disagreement, dominant, double, DSMB, dyskinesia, earliest, electroretinogram, ELX, EMEA, equilibrate, ERSG, ESRD, etiology, exhausted, expedient, exploratory, extracellular, familiarity, Fax, FFB, FFD, FFG, Fighting, Fitzgerald, flat, forskolin, GAPP, GDPR, glycoside, Goodyer, gradual, grown, hair, hallmark, harmonin, headcount, heterogeneity, hindsight, histology, hit, HUB, Hubrecht, imbalance, immunofluorescence, imposition, infancy, infertility, inhibit, inhibition, internet, intravitreal, IRB, IRC, IRD, isolated, junction, KNAW, labor, LCA, Leber, lender, Lending, lessee, lifetime, lumen, Luxturna, lyophilized, matrix, McGill, meaningfully, men, MERTK, mild, moderate, monophosphate, Morristown, mucociliary, multiyear, NanoString, native, nephropathology, Network, night, North, NS, nucleotide, ocular, offshore, onset, organoid, outset, overallotment, overestimate, overnight, overstated, Paul, PCD, phone, photoreceptor, Pigmentosa, PKD, plasmid, polarized, polycystic, polymerase, powder, precise, predetermined, preemptive, prime, proof, PTE, qPCR, quantity, ranking, reaction, readthrough, reconstitution, rectal, redundancy, registry, remove, repaid, repatriated, repeal, repealing, retinal, RHO, ribonucleoprotein, robust, RP, shelf, signal, signaling, Silicon, Snow, sooner, Spark, SPC, sphere, spheroid, stalling, stimulated, substrate, sum, SVB, sweat, sweep, swelling, symptom, synthesized, TAG, taxpayer, TGA, TGG, ticker, titled, Touche, transient, tryptophan, unadjusted, undergone, underperformance, understated, underwriter, underwriting, underwritten, unqualified, unrealized, unstable, Upcoming, upper, urge, USH, USPTO, Utrecht, Valley, vector, version, VIII, visual, voluntarily, Wall, WestRiver, white, wobble, women, Workshop
Removed:
absolute, accredited, activation, allocated, antibody, capability, consisting, conventional, deductible, default, define, demand, detected, digit, distract, distribute, dividend, doubt, efficient, environment, executed, existed, explanatory, forcing, generation, grantee, host, implicated, import, injury, input, interact, intrinsic, issuable, iv, literature, living, mandated, minimal, noted, paragraph, prevailing, progression, prospective, quotation, recognizing, resumed, RSM, strike, subscription, travel, trend, unpaid
Filing tables
Filing exhibits
Related press release
Associated ELOX transcripts
ELOX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-228430 and 333-224207 on Form S-3 and Registration Statement No. 333-224860 on Form S-8 of our reports dated March 14, 2019, relating to the consolidated financial statements of Eloxx Pharmaceuticals, Inc., and the effectiveness of Eloxx Pharmaceuticals, Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Eloxx Pharmaceuticals, Inc. for the year ended December 31, 2018.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 14, 2019